Table 3.
Odds ratios (OR) (with 95% CI) of HER2 positive relative to HER2 negative by different characteristics of CRC patients
| Crude | Adjusted | ||
|---|---|---|---|
| OR (95% CI) P | OR (95% CI) P | ||
| Sex |
Male Female |
Ref. 0.729 (0.465, 1.141) 0.166 |
\ |
| T stage |
T1–T2 T3–T4 |
Ref. 1.072 (0.615, 1.868) 0.806 |
\ |
| N stage |
N0 N1–N2 |
Ref. 0.684 (0.437, 1.071) 0.097 |
Ref. 0.946 (0.553, 1.619) 0.839 |
| Distant metastasis |
Yes No |
Ref. 1.206 (0.617, 2.357) 0.584 | \ |
| TNM stage |
I-II III-IV |
Ref. 0.700 (0.445, 1.100) 0.122 | \ |
| Vessel invasion |
Yes No |
Ref. 0.534 (0.341, 0.835) 0.006 |
Ref. 0.550 (0.322, 0.941) 0.029 |
| Perineural invasion |
Yes No |
Ref. 0.735 (0.466, 1.158) 0.184 | \ |
| Tumor differentiation |
High Poor–moderate |
Ref. 1.415 (0.442, 4.528) 0.559 |
\ |